Skip to content
OpenCapital
Get started

Harmony Biosciences Holdings, Inc. HRMY Earnings yield

Earnings yield at other companies

Jazz Pharmaceuticals logo
Jazz PharmaceuticalsJAZZ
-4.6%-11.2pp
Alkermes logo
AlkermesALKS
2.6%-4.0pp
Axsome Therapeutics logo
Axsome TherapeuticsAXSM
-2.2%-0.8pp
Stoke Therapeutics, Inc. logo
Stoke Therapeutics, Inc.STOK
-8.8%-22.8pp
Amneal Pharmaceuticals, Inc. logo
Amneal Pharmaceuticals, Inc.AMRX
3.1%+2.7pp
Acadia Pharmaceuticals logo
Acadia PharmaceuticalsACAD
9.9%+1.6pp

Other financials

Income statement

See full
Revenue$215.4M+16.6%
Gross profit$170.9M+11.9%
Operating income$37.3M-33.7%
Net income$32.5M-28.7%
EPS (diluted)$0.55-29.5%

Balance sheet

See full
Cash & equivalents$589.4M+20.5%
Total debt$164.6M-7.2%
Total equity$910.3M+26.3%
Total assets$1.3B+20.5%

Cash flow

See full
Operating cash flow$27.8M-18.3%
CapEx$107.0K-79.1%
Free cash flow$126.0M+67.9%

Valuation

See full
Market cap$1.98B-14.9%
Enterprise value$1.55B-24.9%
P/E13.6×-1.6×
P/S2.2×-0.9×

Profitability

See full
Gross margin76.5%-1.8pp
Operating margin21.1%-5.1pp
Net margin16.2%-4.3pp
FCF margin40.1%+9.5pp

Returns & leverage

See full
Return on equity17.9%-6.9pp
Debt / equity0.2×-0.1×
Current ratio3.6×-0.1×

Where this comes from

Calculated from Harmony Biosciences Holdings, Inc.’s reported figures.

net income/market cap=9%

Based on trailing twelve months.

The official record: Harmony Biosciences Holdings, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Harmony Biosciences Holdings, Inc.'s earnings yield.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Harmony Biosciences Holdings, Inc.'s earnings yield?
Harmony Biosciences Holdings, Inc. (HRMY) reported earnings yield of 9% in Q1 2026.
How has Harmony Biosciences Holdings, Inc.'s earnings yield changed year-over-year?
Harmony Biosciences Holdings, Inc.'s earnings yield increased by 12.0% year-over-year, from 8% to 9%.
What is the long-term trend for Harmony Biosciences Holdings, Inc.'s earnings yield?
Over 5 years (2020 to 2025), Harmony Biosciences Holdings, Inc.'s earnings yield has grown at a 32.6% compound annual growth rate (CAGR), from -1.8% to 7.4%.
What does earnings yield mean?
Trailing-twelve-month net income divided by market capitalization at the quarter end — the inverse of the P/E ratio, expressed as a percentage.